Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.700
+0.190 (7.57%)
Aug 6, 2026, 4:00 PM EDT - Market closed
Genelux Revenue
Genelux had revenue of $8.00K in the twelve months ending March 31, 2026. In the year 2025, Genelux had annual revenue of $8.00K.
Revenue (ttm)
$8.00K
Revenue Growth
n/a
P/S Ratio
14,988.01
Revenue / Employee
$308
Employees
26
Market Cap
119.90M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 8.00K | - | - |
| Dec 31, 2024 | 8.00K | -162.00K | -95.29% |
| Dec 31, 2023 | 170.00K | -10.90M | -98.46% |
| Dec 31, 2022 | 11.07M | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cue Biopharma | 32.73M |
| Seer, Inc. | 15.17M |
| Coya Therapeutics | 7.94M |
| Rani Therapeutics Holdings | 3.17M |
| Fractyl Health | 3.00K |
GNLX News
- 5 weeks ago - Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer - GlobeNewsWire
- 7 weeks ago - Genelux Transcript: AGM 2026 - Transcripts
- 3 months ago - Genelux reports Q1 EPS (20c), consensus (19c) - TheFly
- 3 months ago - Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates - GlobeNewsWire
- 3 months ago - Genelux Quarterly report: Q1 2026 - Filings
- 3 months ago - Genelux Earnings release: Q1 2026 - Filings
- 3 months ago - Genelux Slides: Corporate presentation - Filings
- 3 months ago - Genelux Proxy statement: Proxy filing - Filings